alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Arthritis, Rheumatoid in 3 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Joint pain is one of the most debilitating symptoms of rheumatoid arthritis (RA) and patients frequently rate improvements in pain management as their priority." | 1.91 | Insights into FcγR involvement in pain-like behavior induced by an RA-derived anti-modified protein autoantibody. ( Agalave, NM; Barbier, J; Bersellini Farinotti, A; Eijkelkamp, N; Grönwall, C; Hunt, MA; Jimenéz-Andrade, JM; Jurczak, A; Klareskog, L; Krock, E; Marchand, F; Martinez-Martinez, A; Raoof, R; Rudjito, R; Sandor, K; Simon, N; Svensson, CI; Vazquez-Mora, JA; Wang, Z, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Moel, EC | 1 |
| Trouw, LA | 1 |
| Terao, C | 1 |
| Govind, N | 1 |
| Tikly, M | 1 |
| El-Gabalawy, H | 1 |
| Smolik, I | 1 |
| Bang, H | 1 |
| Huizinga, TWJ | 1 |
| Toes, REM | 1 |
| van der Woude, D | 1 |
| Kalafatis, D | 1 |
| Joshua, V | 1 |
| Hansson, M | 1 |
| Mathsson-Alm, L | 1 |
| Hensvold, A | 1 |
| Sköld, M | 1 |
| Jurczak, A | 1 |
| Sandor, K | 1 |
| Bersellini Farinotti, A | 1 |
| Krock, E | 1 |
| Hunt, MA | 1 |
| Agalave, NM | 1 |
| Barbier, J | 1 |
| Simon, N | 1 |
| Wang, Z | 1 |
| Rudjito, R | 1 |
| Vazquez-Mora, JA | 1 |
| Martinez-Martinez, A | 1 |
| Raoof, R | 1 |
| Eijkelkamp, N | 1 |
| Grönwall, C | 1 |
| Klareskog, L | 1 |
| Jimenéz-Andrade, JM | 1 |
| Marchand, F | 1 |
| Svensson, CI | 1 |
3 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Arthritis, Rheumatoid; Autoantibodies; Hum | 2023 |
Presence of anti-modified protein antibodies in idiopathic pulmonary fibrosis.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Arthritis, Rheumatoid; Autoantibodies; Fib | 2023 |
Insights into FcγR involvement in pain-like behavior induced by an RA-derived anti-modified protein autoantibody.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Arthritis, Rheumatoid; Autoantibo | 2023 |